You make it sound like " Technology of Bioxytran "
Post# of 148288
It is not , very early study , especially in COVID-19.
They think blocking galectin is an answer in same patients ..I believe they will have phase 1 trial..
It is interesting what they doing , and possibly it will help some , but lets have little more information for now..
IMO only...